Who
Mark W. Frohlich
Director
Company insider
Files Form 4 as: Director, Rigel Pharmaceuticals; Officer, Juno Therapeutics; EVP, R&D and CMO, Dendreon.
In numbers
- Trades disclosed
- 128
- Buys
- 1
- Sells
- 21
- Bought
- $90K
- Sold
- $6.0M
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 5 Dec 2007
- Last trade
- 15 May 2026
- Last filed
- 19 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 May 2026filed 19 May 2026 | RIGL Rigel PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —5,750 at $0.00 | filing |
| 15 May 2026filed 19 May 2026 | RIGL Rigel PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —5,750 at $0.00 | filing |
| 23 May 2025filed 28 May 2025 | RIGL Rigel Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —1,500 at $0.00 | filing |
| 23 May 2025filed 28 May 2025 | RIGL Rigel PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —1,250 at $0.00 | filing |
| 6 Mar 2025filed 10 Mar 2025 | RIGL Rigel Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 29 Feb 2016filed 2 Mar 2016 | Juno Therapeutics | SEC FORM 4 Sold | $694K19,700 at $35.25 | filing |
| 29 Feb 2016filed 2 Mar 2016 | Juno Therapeutics | SEC FORM 4 Sold | $11K300 at $36.50 | filing |
| 2 Feb 2016filed 4 Feb 2016 | Juno Therapeuticsoption or derivative | SEC FORM 4 Code A | —55,000 at $0.00 | filing |
| 3 Mar 2015filed 5 Mar 2015 | Juno Therapeuticsoption or derivative | SEC FORM 4 Code A | —50,500 at $0.00 | filing |
| 21 Jan 2014filed 22 Jan 2014 | Dendreon | SEC FORM 4 Code F | $1,478459 at $3.22 | filing |
| 20 Jan 2014filed 22 Jan 2014 | Dendreon | SEC FORM 4 Code F | $1,364429 at $3.18 | filing |
| 3 Jan 2014filed 7 Jan 2014 | Dendreon | SEC FORM 4 Code F | $9,4253,060 at $3.08 | filing |
| 3 Jan 2014filed 7 Jan 2014 | Dendreon | SEC FORM 4 Code F | $24K7,713 at $3.08 | filing |
| 3 Jan 2014filed 7 Jan 2014 | Dendreonoption or derivative | SEC FORM 4 Code A | $616K200,000 at $3.08 | filing |
| 21 Oct 2013filed 22 Oct 2013 | Dendreon | SEC FORM 4 Code F | $922384 at $2.40 | filing |
| 20 Oct 2013filed 22 Oct 2013 | Dendreon | SEC FORM 4 Code F | $876359 at $2.44 | filing |
| 3 Oct 2013filed 4 Oct 2013 | Dendreon | SEC FORM 4 Code F | $7,2302,564 at $2.82 | filing |
| 21 Jul 2013filed 23 Jul 2013 | Dendreon | SEC FORM 4 Code F | $1,755384 at $4.57 | filing |
| 20 Jul 2013filed 23 Jul 2013 | Dendreon | SEC FORM 4 Code F | $1,641359 at $4.57 | filing |
| 3 Jul 2013filed 8 Jul 2013 | Dendreon | SEC FORM 4 Code F | $11K2,564 at $4.30 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.